^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CM350
i
Other names: CM350, CM-350
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Keymed Biosciences
Drug class:
CD3 agonist, GPC-3 inhibitor
Related drugs:
over2years
A Study of CM350 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1/2, N=92, Recruiting, Keymed Biosciences Co.Ltd | Not yet recruiting --> Recruiting
Enrollment open
|
GPC3 (Glypican 3)
|
GPC3 positive
|
CM350
almost3years
A Study of CM350 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1/2, N=92, Not yet recruiting, Keymed Biosciences Co.Ltd
New P1/2 trial
|
GPC3 (Glypican 3)
|
GPC3 positive
|
CM350
Share via
